Proof-of-concept : SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders
© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
It is estimated that 20%-67% of those with COVID-19 develop olfactory disorders, depending on the SARS-CoV-2 variant. However, there is an absence of quick, population-wide olfactory tests to screen for olfactory disorders. The purpose of this study was to provide a proof-of-concept that SCENTinel 1.1, a rapid, inexpensive, population-wide olfactory test, can discriminate between anosmia (total smell loss), hyposmia (reduced sense of smell), parosmia (distorted odor perception), and phantosmia (odor sensation without a source). Participants were mailed a SCENTinel 1.1 test, which measures odor detection, intensity, identification, and pleasantness, using one of 4 possible odors. Those who completed the test (N = 287) were divided into groups based on their self-reported olfactory function: quantitative olfactory disorder only (anosmia or hyposmia, N = 135), qualitative olfactory disorder only (parosmia and/or phantosmia; N = 86), and normosmia (normal sense of smell; N = 66). SCENTinel 1.1 accurately discriminates quantitative olfactory disorders, qualitative olfactory disorders, and normosmia groups. When olfactory disorders were assessed individually, SCENTinel 1.1 discriminates between hyposmia, parosmia, and anosmia. Participants with parosmia rated common odors less pleasant than those without parosmia. We provide proof-of-concept that SCENTinel 1.1, a rapid smell test, can discriminate quantitative and qualitative olfactory disorders, and is the only direct test to rapidly discriminate parosmia.
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
---|---|
Enthalten in: |
Chemical senses - 48(2023) vom: 01. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Hunter, Stephanie R [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anosmia |
---|
Anmerkungen: |
Date Completed 22.02.2023 Date Revised 18.02.2024 published: Print UpdateOf: medRxiv. 2022 Nov 08;:. - PMID 35350197 Citation Status MEDLINE |
---|
doi: |
10.1093/chemse/bjad002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353032719 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM353032719 | ||
003 | DE-627 | ||
005 | 20240218231831.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/chemse/bjad002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1298.xml |
035 | |a (DE-627)NLM353032719 | ||
035 | |a (NLM)36796784 | ||
035 | |a (PII)bjad002 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Hunter, Stephanie R |e verfasserin |4 aut | |
245 | 1 | 0 | |a Proof-of-concept |b SCENTinel 1.1 rapidly discriminates COVID-19-related olfactory disorders |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.02.2023 | ||
500 | |a Date Revised 18.02.2024 | ||
500 | |a published: Print | ||
500 | |a UpdateOf: medRxiv. 2022 Nov 08;:. - PMID 35350197 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a It is estimated that 20%-67% of those with COVID-19 develop olfactory disorders, depending on the SARS-CoV-2 variant. However, there is an absence of quick, population-wide olfactory tests to screen for olfactory disorders. The purpose of this study was to provide a proof-of-concept that SCENTinel 1.1, a rapid, inexpensive, population-wide olfactory test, can discriminate between anosmia (total smell loss), hyposmia (reduced sense of smell), parosmia (distorted odor perception), and phantosmia (odor sensation without a source). Participants were mailed a SCENTinel 1.1 test, which measures odor detection, intensity, identification, and pleasantness, using one of 4 possible odors. Those who completed the test (N = 287) were divided into groups based on their self-reported olfactory function: quantitative olfactory disorder only (anosmia or hyposmia, N = 135), qualitative olfactory disorder only (parosmia and/or phantosmia; N = 86), and normosmia (normal sense of smell; N = 66). SCENTinel 1.1 accurately discriminates quantitative olfactory disorders, qualitative olfactory disorders, and normosmia groups. When olfactory disorders were assessed individually, SCENTinel 1.1 discriminates between hyposmia, parosmia, and anosmia. Participants with parosmia rated common odors less pleasant than those without parosmia. We provide proof-of-concept that SCENTinel 1.1, a rapid smell test, can discriminate quantitative and qualitative olfactory disorders, and is the only direct test to rapidly discriminate parosmia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a anosmia | |
650 | 4 | |a hyposmia | |
650 | 4 | |a parosmia | |
650 | 4 | |a phantosmia | |
650 | 4 | |a prediction | |
650 | 4 | |a smell test | |
700 | 1 | |a Hannum, Mackenzie E |e verfasserin |4 aut | |
700 | 1 | |a Pellegrino, Robert |e verfasserin |4 aut | |
700 | 1 | |a O'Leary, Maureen A |e verfasserin |4 aut | |
700 | 1 | |a Rawson, Nancy E |e verfasserin |4 aut | |
700 | 1 | |a Reed, Danielle R |e verfasserin |4 aut | |
700 | 1 | |a Dalton, Pamela H |e verfasserin |4 aut | |
700 | 1 | |a Parma, Valentina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Chemical senses |d 1993 |g 48(2023) vom: 01. Jan. |w (DE-627)NLM074960482 |x 1464-3553 |7 nnns |
773 | 1 | 8 | |g volume:48 |g year:2023 |g day:01 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/chemse/bjad002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 48 |j 2023 |b 01 |c 01 |